Additionally, type I IFNs promote aromatase synthesis in adipose tissue surrounding BC and recruit the HIF1α-IFI16/204-PRMT2 complex to the aromatase promoter, PI.3/PII, which amplifies E2-dependent BC proliferation64. Here, IFI16 is linked to breast cancer.